Rehabmart is an AOTA Approved Provider of professional development. Course approval ID# 9031. This Distance Learning - Independent activity is offered at .125 CEUs, intermediate level, Occupational Therapy Service Delivery. The assignment of AOTA CEUs does not imply endorsement of specific course content, products, or clinical procedures by AOTA or indicate AOTA approval of a certification or other professional recognition.
Course Overview
This AOTA approved continuing education class will introduce you to efficacous evidence-based interventions that drive neuroplastic change resulting in improved functional recovery in the upper limb following stroke.
The online class is intended for medical professionals (e.g. OT/OTA, PT/PTA, Physicians, etc.) directly related to the rehabilitation of a patient or client. To participate in this CEU and receive credit, the participant must be a licensed, treating clinician. Completion of this course will reward the participant with .125 CEUs or 1.25 contact hours, following completion of the presentation and a ≥ 80% score on the quiz. You will have 90 days to complete this course.
-
-
Overview
-
Learning Outcomes
-
Manual and References
-
Watch Course
-
Course Review
-
Quiz
-
Course Feedback
-
About this course
- 1.25 Contact Hours / .125 CEU
- Online Self-Study Course
- Speaker Video and Slide Content
Learning Outcomes
-
Analyze stroke outcome statistics and trends.
-
Compare the differences between the umbra and the penumbra and the effects on the brain following stroke.
-
Analyze learned nonuse and its direct effects on functional recovery.
-
Classify what is and what is not considered effective when attempting to drive neuroplasticity during treatment.
-
Differentiate between evidence-based treatments that are considered beneficial vs. inconclusive.
Instructor(s)
Henry Hoffman
MS, OTR/L
Henry is known as a purveyor of neuroplasticity-based treatment and co-founder of Saebo, a leading provider of novel and evidence-based stroke recovery solutions. For over 20 years, he has provided hundreds of national and international brain injury/stroke courses certifying thousands of occupational and physical therapists worldwide.
Henry’s first stroke product, the SaeboFlex, was placed on permanent public display at the Wellcome Medicine Galleries exhibit at the Science Museum in London. The SaeboFlex was alongside other medical breakthrough technologies spanning the last 500 years, including the first MRI machine and the penicillin mold.
With the understanding that there is no expiration date on neuroplasticity, Henry believes that patients can continue to make gains many years post-stroke and live a happy, healthy, and more independent life.